1. Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant. Issue 2 (17th February 2022) Authors: Jullien, Maxime; Coste‐Burel, Marianne; Clemenceau, Beatrice; Letailleur, Valentin; Guillaume, Thierry; Peterlin, Pierre; Garnier, Alice; Bourgeois, Amandine Le; Imbert, Berthe‐Marie; Ollier, Jocelyn; Grain, Audrey; Touzeau, Cyrille; Moreau, Philippe; Béné, Marie C; Vié, Henri; Chevallier, Patrice Journal: EJHaem Issue: Volume 3:Issue 2(2022) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients. (11th May 2020) Authors: Peterlin, Pierre; Cluzeau, Thomas; Jullien, Maxime; Ngo Nloga, Anne‐Marie; Calleja, Anne; Angeli, Eurydice; Chevallier, Patrice; Guillaume, Thierry; Garnier, Alice; Le Bourgeois, Amandine; Le Gouill, Steven; Fenaux, Pierre; Adès, Lionel; Bally, Cécile Journal: British journal of haematology Issue: Volume 190:Number 3(2020) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effectiveness of a third dose of BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccine over a 6‐month follow‐up period in allogenic hematopoietic stem cells recipients. Issue 5 (29th April 2022) Authors: Chevallier, Patrice; Jullien, Maxime; Peterlin, Pierre; Garnier, Alice; Le Bourgeois, Amandine; Coste‐Burel, Marianne; Béné, Marie C.; Guillaume, Thierry Journal: Hematological oncology Issue: Volume 40:Issue 5(2022) Page Start: 1097 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation. Issue 4 (28th September 2022) Authors: Garnier, Alice; Bourgeois, Amandine Le; Guillaume, Thierry; Peterlin, Pierre; Jullien, Maxime; Coste‐Burel, Marianne; Béné, Marie C; Chevallier, Patrice Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide. (21st September 2021) Authors: Jullien, Maxime; Orvain, Corentin; Berceanu, Ana; Couturier, Marie‐Anne; Guillaume, Thierry; Peterlin, Pierre; Garnier, Alice; Le Bourgeois, Amandine; Klemencie, Marion; Schmidt, Aline; Hunault, Mathilde; Daguindau, Etienne; Roussel, Xavier; Delepine, Pascal; Guillerm, Gaelle; Giltat, Aurelien; F... Journal: Cancer medicine Issue: Volume 10:Number 20(2021) Page Start: 7194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant. (20th October 2021) Authors: Le Bourgeois, Amandine; Coste‐Burel, Marianne; Guillaume, Thierry; Peterlin, Pierre; Garnier, Alice; Imbert, Berthe‐Marie; Drumel, Thomas; Mahé, Beatrice; Dubruille, Viviane; Blin, Nicolas; Lok, Anne; Touzeau, Cyrille; Gastinne, Thomas; Tessoulin, Benoît; Jullien, Maxime; Vantyghem, Sophie; Morea... Journal: British journal of haematology Issue: Volume 196:Number 5(2022) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response. (1st January 2021) Authors: Makanga, Dhon Roméo; Jullien, Maxime; David, Gaëlle; Legrand, Nolwenn; Willem, Catherine; Dubreuil, Léa; Walencik, Alexandre; Touzeau, Cyrille; Gastinne, Thomas; Tessoulin, Benoit; Le Gouill, Steven; Mahé, Béatrice; Gagne, Katia; Chevallier, Patrice; Clemenceau, Béatrice; Retière, Christelle Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Monoclonal antibodies as an addition to current myeloma therapy strategies. Issue 1 (2nd January 2021) Authors: Jullien, Maxime; Touzeau, Cyrille; Moreau, Philippe Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 1(2021) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Peripheral levels of monocytic myeloid‐derived suppressive cells before and after first induction predict relapse and survivals in AML patients. Issue 21 (13th October 2022) Authors: Peterlin, Pierre; Debord, Camille; Eveillard, Marion; Garnier, Alice; Le Bourgeois, Amandine; Guillaume, Thierry; Jullien, Maxime; Béné, Marie C.; Chevallier, Patrice Journal: Journal of cellular and molecular medicine Issue: Volume 26:Issue 21(2022) Page Start: 5486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Post‐transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced‐intensity conditioning allotransplant. Issue 4 (26th April 2023) Authors: Bourgeois, Amandine Le; Jullien, Maxime; Garnier, Alice; Peterlin, Pierre; Béné, Marie C.; Guillaume, Thierry; Chevallier, Patrice Journal: Clinical and translational medicine Issue: Volume 13:Issue 4(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗